Literature DB >> 6527705

In vivo and in vitro dopaminergic effects of three ergoline fragments.

J C Koons, J P Long, J G Cannon.   

Abstract

The pharmacological effects of three ergoline fragments (BD-179, BD-271 and BD-214) were studied in vivo using the cat cardioaccelerator nerve preparation and in vitro using field stimulated isolated cat right atria. BD-179 and BD-271 produced dose dependent inhibition of tachycardia due to electrical stimulation of the right postganglionic cardioaccelerator nerve in anesthetized cats, BD-214 was inactive. BD-179 produced primarily hypotension, BD-271 produced a transient pressor response followed by hypotension and BD-214 produced only pressor effects. The tachycardia inhibitory effects and hypotension produced by BD-179 and BD-271 were antagonized by the dopamine receptor antagonist sulpiride. BD-179, BD-271 and BD-214 antagonized the presynaptic inhibitory effects of the dopamine receptor agonist apomorphine in vitro on field stimulated isolated cat right atria. All three ergoline fragments facilitated stimulation-induced increases in systolic tension development and BD-214 facilitated stimulation-induced tachycardia in isolated cat right atria.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6527705     DOI: 10.1007/bf00512069

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  31 in total

Review 1.  Developments in the pharmacology and therapeutics of parkinsonism.

Authors:  D B Calne
Journal:  Ann Neurol       Date:  1977-02       Impact factor: 10.422

2.  Inhibition by dopamine of 3H-noradrenaline release elicited by nerve stimulation in the isolated cat's nictitating membrane.

Authors:  M A Enero; S Z Langer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

3.  Evidence for a peripheral dopaminergic mechanism in the antihypertensive action of lergotrile.

Authors:  A F Sved; J D Fernstrom
Journal:  Life Sci       Date:  1980-07-28       Impact factor: 5.037

4.  Dopaminergic inhibition of cardiac sympathetic nerve function by pergolide.

Authors:  R J Barrett; M F Lokhandwala
Journal:  Eur J Pharmacol       Date:  1982-01-08       Impact factor: 4.432

5.  Dopamine receptor mediated inhibition by bromocriptine of accelerator nerve stimulation effects in the pithed cat [proceedings].

Authors:  G Scholtysik; B Berde
Journal:  Br J Pharmacol       Date:  1978-03       Impact factor: 8.739

6.  The effect of dopamine on the overflow of endogenous noradrenaline from the perfused rabbit heart evoked by sympathetic nerve stimulation.

Authors:  H Fuder; E Muscholl
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-11       Impact factor: 3.000

7.  Hepatocellular injury with distinctive mitochondrial changes induced by lergotrile mesylate: a dopaminergic ergot derivative.

Authors:  P F Teychenne; E A Jones; K G Ishak; D B Calne
Journal:  Gastroenterology       Date:  1979-03       Impact factor: 22.682

8.  Inhibition of the sympathetic nervous system by a series of heterocyclic congeners of dopamine.

Authors:  F M Sharabi; J P Long; J G Cannon; G J Hatheway
Journal:  J Pharmacol Exp Ther       Date:  1976-12       Impact factor: 4.030

9.  Analysis of the effects of bromocriptine on blood pressure and sympathetic nerve function.

Authors:  M F Lokhandwala
Journal:  Eur J Pharmacol       Date:  1979-06-15       Impact factor: 4.432

10.  Antagonist properties of phentolamine at both presynaptic alpha 2-adrenoceptors and presynaptic dopamine receptors using field stimulated right cat atria.

Authors:  J C Koons; J R Flynn; J P Long
Journal:  Eur J Pharmacol       Date:  1983-04-08       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.